Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - COVID-19 Prevention
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN
  - IgAN & C3G
  - Renal Transplant Maintenance
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Wet AMD
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - COPD
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Psoriatic Arthritis
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Urology
  - BACK
  - Urology
  - Uncomplicated Urinary Tract Infections
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

experspadmin

Frontline Treatment Options for Patients With Chronic Lymphocytic Leukemia and Significant Comorbidity

Frontline Treatment Options for Patients With Chronic Lymphocytic Leukemia and Significant Comorbidity

expert roundtables
By Matthew S. Davids, MD, MMSc; William G. Wierda, MD, PhD

$Emerging Options for Relapsed/Refractory Chronic Lymphocytic Leukemia$

Emerging Options for Relapsed/Refractory Chronic Lymphocytic Leukemia

expert roundtables
By Matthew S. Davids, MD, MMSc; William G. Wierda, MD, PhD

Prognostic Marker Testing in Treatment-Naive Patients With Chronic Lymphocytic Leukemia

Prognostic Marker Testing in Treatment-Naive Patients With Chronic Lymphocytic Leukemia

patient care perspectives
By William G. Wierda, MD, PhD

Patient and Physician Decision Making on the Use of Novel Agents in Chronic Lymphocytic Leukemia

Patient and Physician Decision Making on the Use of Novel Agents in Chronic Lymphocytic Leukemia

patient care perspectives

Potential Role of Novel Agent Triplets in Treatment-Naive Chronic Lymphocytic Leukemia

Potential Role of Novel Agent Triplets in Treatment-Naive Chronic Lymphocytic Leukemia

clinical topic updates
By Matthew S. Davids, MD, MMSc

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?